User profiles for "author:Shivanshan Pathmanathan"
Shivanshan PathmanathanAssociate lecturer. James Cook University Verified email at health.qld.gov.au Cited by 77 |
[HTML][HTML] Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell …
Purpose There is an emerging role of the use of Prostate-Specific Membrane Antigen
(PSMA) Positron Emission Tomography (PET) in renal cell carcinoma. Herein, we report our …
(PSMA) Positron Emission Tomography (PET) in renal cell carcinoma. Herein, we report our …
Delays in lung cancer management pathways between rural and urban patients in North Queensland: a mixed methods study
R Verma, S Pathmanathan, ZA Otty… - Internal medicine …, 2018 - Wiley Online Library
Background Despite advances in medical therapies, disparity in outcome between rural and
urban patients remain in Australia and many Western countries. Aims To examine time …
urban patients remain in Australia and many Western countries. Aims To examine time …
Maintaining dose intensity of adjuvant chemotherapy in older patients with breast cancer
Introduction Maintaining the relative dose intensity (RDI) of adjuvant chemotherapy at≥
85% has been associated with improved treatment outcomes in early-stage breast cancer …
85% has been associated with improved treatment outcomes in early-stage breast cancer …
Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis
S Pathmanathan, H Babu, M Dzienis… - Pigment Cell & …, 2022 - Wiley Online Library
Combination immunotherapy with nivolumab and ipilimumab is an effective therapy in the
treatment of metastatic melanoma, however, its benefit in older patients is unclear. A …
treatment of metastatic melanoma, however, its benefit in older patients is unclear. A …
[HTML][HTML] Salmonella empyema: a case report
S Pathmanathan, S Welagedara, P Dorrington… - Pneumonia, 2015 - Springer
Non-typhi Salmonella enterica infection rarely presents as a pleural empyema, with only 31
cases published in the literature over the last century. We report a case of an 85-year-old …
cases published in the literature over the last century. We report a case of an 85-year-old …
Cetuximab associated dermal filler reaction
S Pathmanathan, M Dzienis - BMJ Case Reports CP, 2019 - casereports.bmj.com
A 52-year-old male patient with hyaluronic acid-based dermal fillers injected in his cheeks
was diagnosed with glossotonsillary malignancy, and managed with concurrent cetuximab …
was diagnosed with glossotonsillary malignancy, and managed with concurrent cetuximab …
[HTML][HTML] The limited role of cranial computerised tomography in the assessment of a medical patient
S Pathmanathan, S Welagedara, K Mutalithas - Clinical Medicine, 2015 - ncbi.nlm.nih.gov
Methods All patients referred to the MAU over a three-month period who underwent cranial
CT scans were examined. Some of these patients also went on to have MRI of the brain. 192 …
CT scans were examined. Some of these patients also went on to have MRI of the brain. 192 …
Early discontinuation rates of aromatase inhibitors due to musculoskeletal side effects
C Owens, V Andelkovic, S Pathmanathan… - Breast Cancer …, 2016 - Future Medicine
Aim: We conducted a single institution retrospective review to assess early rates of
discontinuation of aromatase inhibitors (AI) due to musculoskeletal adverse effects …
discontinuation of aromatase inhibitors (AI) due to musculoskeletal adverse effects …
Multicentre retrospective assessment of toxicity and response to immunotherapy in elderly patients with metastatic melanoma.
S Pathmanathan, HS Babu, R Mason, S Htut, ZA Otty… - 2021 - ascopubs.org
9565 Background: The incidence of melanoma increases with age, however, elderly
patients remain under-represented in landmark immunotherapy trials for metastatic …
patients remain under-represented in landmark immunotherapy trials for metastatic …
Toxicity and response to ipilimumab and nivolumab in elderly patients with metastatic melanoma: A multicenter retrospective analysis.
S Pathmanathan, HS Babu, MR Dzienis, M Azer… - 2022 - ascopubs.org
e21540 Background: Dual immunotherapy (nivolumab and ipilimumab) is an effective
therapy in the treatment of metastatic melanoma, however, its benefit in older patients is …
therapy in the treatment of metastatic melanoma, however, its benefit in older patients is …